Cargando…

The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation

The bone destruction disease including osteoporosis and rheumatoid arthritis are caused by the imbalance between osteoblastogenesis and osteoclastogenesis. Inhibition of the NF-κB pathway was responsible for decreased osteoclastogenesis. Recently many studies indicated that niclosamide, the FDA appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fei-Lan, Chen, Chun-Liang, Lee, Chia-Chung, Wu, Cheng-Chi, Hsu, Teng-Hsu, Tsai, Chang-Youh, Huang, Hsu-Shan, Chang, Deh-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562191/ https://www.ncbi.nlm.nih.gov/pubmed/28824321 http://dx.doi.org/10.7150/ijms.19268

Ejemplares similares

Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone
por: Xiong, Jinhu, et al.
Publicado: (2015)

Osteoclast regulation of osteoblasts via RANK-RANKL reverse signal transduction in vitro
por: Zhang, Shiqian, et al.
Publicado: (2017)

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
por: He, Jianbo, et al.
Publicado: (2021)

Serum Insufficiency Induces RANKL-Independent Osteoclast Formation during Developing Ischemic ONFH
por: Hsiao, Yi-min, et al.
Publicado: (2021)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
por: Jiao, Yurui, et al.
Publicado: (2020)

Serum amyloid A inhibits RANKL-induced osteoclast formation
por: Oh, Eunseo, et al.
Publicado: (2015)

The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation
por: Qu, Hongyi, et al.
Publicado: (2021)

CD146(+) mesenchymal stem cells display greater therapeutic potential than CD146(–) cells for treating collagen-induced arthritis in mice
por: Wu, Cheng-Chi, et al.
Publicado: (2016)

Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF–RANKL signaling
por: Bartelt, Alexander, et al.
Publicado: (2018)

MicroRNA-26a Regulates RANKL-Induced Osteoclast Formation
por: Kim, Kabsun, et al.
Publicado: (2015)

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
por: Hu, Zi’ang, et al.
Publicado: (2018)

RANKL-RANK signaling regulates osteoblast differentiation and bone formation
por: Cao, Xu
Publicado: (2018)

Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor
por: Persson, Emma, et al.
Publicado: (2019)

PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling
por: Li, Shangfu, et al.
Publicado: (2020)

Inhibitory Effect of Cudratrixanthone U on RANKL-Induced Osteoclast Differentiation and Function in Macrophages and BMM Cells
por: Kim, Eun-Nam, et al.
Publicado: (2020)

Inhibitory Effects of Protopanaxadiol-Producing Transgenic Rice Seed Extracts on RANKL-Induced Osteoclast Differentiation
por: Lee, Yongjin, et al.
Publicado: (2022)

Earthworm (Pheretima aspergillum) extract stimulates osteoblast activity and inhibits osteoclast differentiation
por: Fu, Yuan-Tsung, et al.
Publicado: (2014)

TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation
por: Marahleh, Aseel, et al.
Publicado: (2019)

Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model
por: Zhu, Sheng, et al.
Publicado: (2020)

Inhibitory Effect of Chrysanthemum zawadskii Herbich var. latilobum Kitamura Extract on RANKL-Induced Osteoclast Differentiation
por: Gu, Dong Ryun, et al.
Publicado: (2013)

4-Hydroxyderricin inhibits osteoclast formation and accelerates osteoblast differentiation
por: Hagiwara, Hiromi, et al.
Publicado: (2018)

Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss
por: Xiong, Jinhu, et al.
Publicado: (2018)

RO4929097 regulates RANKL-induced osteoclast formation and LPS-mediated bone resorption
por: Huang, Tao, et al.
Publicado: (2021)

A new niclosamide derivatives‐B17 can inhibit urological cancers growth through apoptosis‐related pathway
por: Wu, Chia‐Lun, et al.
Publicado: (2018)

Signaling crosstalk between RANKL and interferons in osteoclast differentiation
por: Takayanagi, Hiroshi, et al.
Publicado: (2002)

Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation
por: Han, Sang-Yong, et al.
Publicado: (2018)

Influence of Angptl1 on osteoclast formation and osteoblastic phenotype in mouse cells
por: Ishida, Masayoshi, et al.
Publicado: (2021)

Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways
por: Yuan, Yu, et al.
Publicado: (2020)

Piperlongumine Inhibits Titanium Particles-Induced Osteolysis, Osteoclast Formation, and RANKL-Induced Signaling Pathways
por: Liu, Xuan, et al.
Publicado: (2022)

Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation
por: Miyagawa, Kazuaki, et al.
Publicado: (2023)

Therapeutic Effect of Calcimimetics on Osteoclast–Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease
por: Hung, Kuo-Chin, et al.
Publicado: (2020)

In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates
por: Lawal, Bashir, et al.
Publicado: (2023)

Effect of zinc substitution in hydroxyapatite coating on osteoblast and osteoclast differentiation under osteoblast/osteoclast co-culture
por: Meng, Guolong, et al.
Publicado: (2019)

RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro
por: Sutherland, Karen A, et al.
Publicado: (2009)

RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis
por: Yue, Zhiying, et al.
Publicado: (2022)

Clathrin-dependent endocytosis of membrane-bound RANKL in differentiated osteoclasts
por: Narducci, P., et al.
Publicado: (2010)

Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression
por: Hwang, Youn-Hwan, et al.
Publicado: (2018)

Excessive osteoclast activation by osteoblast paracrine factor RANKL is a major cause of the abnormal long bone phenotype in Apert syndrome model mice
por: Shin, Hye‐Rim, et al.
Publicado: (2022)

Osteoblast-Osteoclast Communication and Bone Homeostasis
por: Kim, Jung-Min, et al.
Publicado: (2020)

RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation
por: Chen, Xiao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l35pc3p9e9sj2rdt5n5nobpc7u